Intercept Offloads Ex-US Business To Advanz, May Be Doubling Down On NASH In US

 
• By Joseph Haas
International deal
Intercept dealt ex-US rights to Ocaliva to Advanz Pharma • Source: Alamy

More from Deals

More from Business